Trial · NCT02898259
Participant flow15
How many started, completed or left each group, period by period.
1 to 15 of 15
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | DL1 (Ixazomib 2.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 3 | |
| Overall Study | STARTED | DL2 (Ixazomib 3.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 3 | |
| Overall Study | STARTED | DL3/MTD (Ixazomib 4.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 6 | |
| Overall Study | STARTED | Expansion Cohort I: Follicular Lymphoma at MTD | 7 | |
| Overall Study | STARTED | Expansion Cohort 2: Non-Follicular Lymphoma at MTD | 0 | |
| Overall Study | COMPLETED | DL1 (Ixazomib 2.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 2 | |
| Overall Study | COMPLETED | DL2 (Ixazomib 3.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 2 | |
| Overall Study | COMPLETED | DL3/MTD (Ixazomib 4.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 1 | |
| Overall Study | COMPLETED | Expansion Cohort I: Follicular Lymphoma at MTD | 6 | |
| Overall Study | COMPLETED | Expansion Cohort 2: Non-Follicular Lymphoma at MTD | 0 | |
| Overall Study | NOT COMPLETED | DL1 (Ixazomib 2.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 1 | |
| Overall Study | NOT COMPLETED | DL2 (Ixazomib 3.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 1 | |
| Overall Study | NOT COMPLETED | DL3/MTD (Ixazomib 4.0 mg + Lenalidomide 20 mg + Rituximab 375mg/m2) | 5 | |
| Overall Study | NOT COMPLETED | Expansion Cohort I: Follicular Lymphoma at MTD | 1 | |
| Overall Study | NOT COMPLETED | Expansion Cohort 2: Non-Follicular Lymphoma at MTD | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02898259/flow